Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to difficulties in academic and professional life but also as a major cause of suicide in ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

Another of the psychiatry drugs Neurocrine Biosciences licensed from Takeda has stumbled in the clinic. | Another of the ...

Researchers investigated the impact of transcranial electrical stimulation interventions on treatment of depressive symptoms.

Genetic differences in early- and late-onset depression highlight distinct risk profiles, informing targeted strategies for ...

Payers provide insights to health care disparities currently impacting patients with major depressive disorder (MDD). Jay Weaver, PharmD, MPH: When we’ve looked at health equity and disparities in ...

Major depressive disorder (MDD), perhaps the most common form of depression (APA, 2013), has many subtypes, each with its unique characteristics and treatment needs. I was recently reviewing this with ...

A new study suggests a connection between the consumption of soft drinks and major depressive disorder, potentially acting ...

Some mental conditions can make day-to-day living difficult. In You're Not Alone, we highlight how people cope with their emotions and manage their conditions on a daily basis. We include products we ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...